Notification for retail price fixation of new drugs for 42 applications

REGD. No. D. L.-33004/99 The Gazette of India CG-DL-E-02052026-272214 EXTRAORDINARY PART II—Section 3—Sub-section (ii) PUBLISHED BY AUTHORITY No. 2086] NEW DELHI, THRUSDAY, APRIL 30, 2026/VAISAKHA 10, 1948 MINISTRY OF CHEMICALS AND FERTILIZERS (Department of Pharmaceuticals) (NATIONAL PHARMACEUTICAL PRICING AUTHORITY) ORDER New Delhi, the 30th April, 2026 S.O. 2167(E).— In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S.O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof; TABLE +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | SI. | Name of the Formulation | Strength | Unit | Manufacturer | Retail | | No | / Brand Name | | | & Marketing | Price | | | | | | Company | (Rs.) | +=====+========================================================+================================================================================+==========+=============================================================+=========+ | (1) | (2) | (3) | (4) | (5) | (6) | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 1 | Aceclofenac, Paracetamol | Each film coated tablet contains: | 1 Tablet | M/s Pinnacle | 10.18 | | | & Serratiopeptidase | Aceclofenac IP 100 mg | | Life Science | | | | Tablets | Paracetamol IP 325 mg | | Pvt. Ltd./ | | | | | Serratiopeptidase IP 15 mg | | M/s Softdeal | | | | | (As enteric coated eq. to enzyme | | Pharmaceutica | | | | | activity 30,000 units) | | l Pvt. Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 2 | Acetylcysteine & Taurine | Each film coated tablet contains: | 1 Tablet | M/s Talent | 14.72 | | | Tablets | Acetylcysteine USP 150 mg | | Healthcare/ | | | | | Taurine USP 500 mg | | M/s Zorvia | | | | | | | Healthcare | | | | | | | Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 3 | Albendazole & | Each uncoated chewable tablet | 1 Tablet | M/s Theta | 29.60 | | | Ivermectin Tablets | contains: | | Pharmaceutica | | | | | Albendazole IP 400 mg | | ls Ltd./ | | | | | Ivermectin IP 6 mg | | M/s Aristo | | | | | | | Laboratories | | | | | | | Pvt. Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 4 | Atorvastatin & Ezetimibe | Each film coated tablet contains: | 1 Tablet | M/s East | 21.36 | | | Tablets | Atorvastatin Calcium IP | | African (I) | | | | | eq. to Atorvastatin 10mg | | Overseas/ | | | | | Ezetimibe IP 10mg | | M/s Aristo | | | | | | | Pharmaceutica | | | | | | | ls Pvt. Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 5 | Atorvastatin & Ezetimibe | Each film coated tablet contains: | 1 Tablet | M/s East | 27.50 | | | Tablets | Atorvastatin Calcium IP | | African (I) | | | | | eq. to Atorvastatin 20mg | | Overseas/ | | | | | Ezetimibe IP 10mg | | M/s Aristo | | | | | | | Pharmaceutica | | | | | | | ls Pvt. Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 6 | Atorvastatin & Ezetimibe | Each film coated tablet contains: | 1 Tablet | M/s East | 32.46 | | | Tablets | Atorvastatin Calcium IP | | African (I) | | | | | eq. to Atorvastatin 40mg | | Overseas/ | | | | | Ezetimibe IP 10mg | | M/s Aristo | | | | | | | Pharmaceutica | | | | | | | ls Pvt. Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 7 | Atorvastatin and | Each hard gelatin capsule contains: | 1 Capsule| M/s Safetab | 15.36 | | | Clopidogrel Capsules | Atorvastatin Calcium IP eq. to | | Life Science/ | | | | | Atorvastatin 10 mg (as pellets) | | M/s Corona | | | | | Clopidogrel Bisulphate IP eq. to | | Remedies Ltd. | | | | | Clopidogrel 75 mg (as pellets) | | | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 8 | Atorvastatin and | Each hard gelatin capsule contains: | 1 Capsule| M/s Safetab | 20.96 | | | Clopidogrel Capsules | Atorvastatin Calcium IP eq. to | | Life Science/ | | | | | Atorvastatin 20 mg (as pellets) | | M/s Corona | | | | | Clopidogrel Bisulphate IP eq. to | | Remedies Ltd. | | | | | Clopidogrel 75 mg (as pellets) | | | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 9 | Atorvastatin and | Each hard gelatin capsule contains: | 1 Capsule| M/s Windlas | 30.48 | | | Clopidogrel Capsules | Atorvastatin Calcium IP eq. to | | Biotech Ltd./ | | | | | Atorvastatin 40 mg | | M/s Corona | | | | | (As green coloured spherical pellets) | | Remedies Ltd. | | | | | Clopidogrel Bisulphate IP eq. to | | | | | | | Clopidogrel 75 mg | | | | | | | (As two brown coloured film coated | | | | | | | tablets Each containing 37.5 mg | | | | | | | Clopidogrel Tablets IP) | | | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 10 | Cefixime & Potassium | Each film coated tablet contains: | 1 Tablet | M/s Purobien | 25.00 | | | Clavulanate Tablets | Cefixime (as Trihydrate) IP | | Lifesciences/ | | | | | eq. to Anhydrous Cefixime | | M/s Unison | | | | | 200 mg | | Pharmaceutica | | | | | Potassium Clavulanate Diluted IP | | ls Pvt. Ltd. | | | | | Eq. to Clavulanic Acid 125 mg | | | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 11 | Cefuroxime Axetil & | Each film coated tablet contains: | 1 Tablet | M/s Associated | 38.35 | | | Potassium Clavulanate | Cefuroxime Axetil IP eq. to Cefuroxime | | Biopharma | | | | Tablets | 250 mg | | Pvt. Ltd./ | | | | | Potassium Clavulanate Diluted IP eq. to | | M/s German | | | | | Clavulanic Acid 125 mg | | Remedies | | | | | | | Pharmaceutica | | | | | | | ls Pvt. Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 12 | Cefuroxime Axetil & | Each film coated tablet contains: | 1 Tablet | M/s Associated | 63.94 | | | Potassium Clavulanate | Cefuroxime Axetil IP eq. to Cefuroxime | | Biopharma | | | | Tablets | 500 mg | | Pvt. Ltd./ | | | | | Potassium Clavulanate Diluted IP eq. to | | M/s German | | | | | Clavulanic Acid 125 mg | | Remedies | | | | | | | Pharmaceutica | | | | | | | ls Pvt. Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 13 | Cefuroxime Axetil | Each film coated tablet contains: | 1 Tablet | M/s Skymap | 28.41 | | | Tablets | Cefuroxime Axetil IP | | Pharmaceutica | | | | | eq. to Anhydrous Cefuroxime 250 mg | | ls Pvt. Ltd./ | | | | | | | M/s Glensmith | | | | | | | Labs Pvt. Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 14 | Cefuroxime Axetil | Each film coated tablet contains: | 1 Tablet | M/s Theon | 29.42 | | | Tablets | Cefuroxime Axetil IP | | Pharmaceutica | | | | | eq. to Anhydrous Cefuroxime 250 mg | | ls Ltd./ | | | | | | | M/s Aristo | | | | | | | Laboratories | | | | | | | Pvt. Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 15 | Clopidogrel, Aspirin & | Each hard gelatin capsule contains: | 1 Capsule| M/s Safetab | 6.19 | | | Atorvastatin Capsules | Clopidogrel Bisulphate IP eq. to | | Life Science/ | | | | | Clopidogrel 75 mg | | M/s Corona | | | | | Aspirin IP 75mg (as Gastro-resistant | | Remedies Ltd. | | | | | tablet) | | | | | | | Atorvastatin Calcium IP eq. to | | | | | | | Atorvastatin 10 mg (as film coated | | | | | | | tablet) | | | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 16 | Clopidogrel, Aspirin & | Each hard gelatin capsule contains: | 1 Capsule| M/s Safetab | 8.80 | | | Atorvastatin Capsules | Clopidogrel Bisulphate IP eq. to | | Life Science/ | | | | | Clopidogrel 75 mg | | M/s Corona | | | | | Aspirin IP 75 mg (as Gastro-Resistant | | Remedies Ltd. | | | | | Tablet) | | | | | | | Atorvastatin Calcium IP eq. to | | | | | | | Atorvastatin 20 mg (as film coated | | | | | | | tablet) | | | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 17 | Etoricoxib & Paracetamol | Each film coated tablet contains: | 1 Tablet | M/s Aagya | 10.58 | | | Tablets | Etoricoxib IP 60 mg | | Biotech Pvt. | | | | | Paracetamol IP 325 mg | | Ltd./ | | | | | | | M/s German | | | | | | | Remedies | | | | | | | Pharmaceutica | | | | | | | ls Pvt. Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 18 | Ferric Ammonium | Each 15 ml (one tablespoonful) | 1 ml | M/s Crest | 0.88 | | | Citrate, | contains: | | Lifesciences | | | | Cyanocobalamin, Folic | Ferric Ammonium Citrate IP 160mg | | Pvt. Ltd./ | | | | Acid, Cupric Sulphate & | (eq. to Elemental Iron 32.8 mg) | | M/s Troikaa | | | | Manganese Sulphate | Cyanocobalamin IP 7.5 mcg | | Pharmaceutica | | | | Syrup | Folic Acid IP 0.5 mg | | ls Ltd. | | | | | Cupric Sulphate USP 30 mcg | | | | | | | Manganese Sulphate USP 30 mcg | | | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 19 | Gliclazide & Metformin | Each uncoated tablet contains: | 1 Tablet | M/s Alkem | 10.53 | | | Hydrochloride Tablets | Gliclazide IP 80 mg | | Health Science | | | | | Metformin Hydrochloride 500 mg | | (A unit of | | | | | | | Alkem | | | | | | | Laboratories | | | | | | | Ltd.)/ | | | | | | | M/s Alkem | | | | | | | Wellness Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 20 | Ivermectin & | Each uncoated chewable tablet | 1 Tablet | M/s Ved | 29.60 | | | Albendazole | contains: | | Lifesavers (P) | | | | Tablets | Ivermectin IP 6 mg | | Ltd./ | | | | | Albendazole IP 400 mg | | M/s | | | | | | | Wockhardt | | | | | | | Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 21 | Labetalol Hydrochloride | Each film coated tablet contains: | 1 Tablet | M/s Samarth | 23.17 | | | Tablets | Labetalol Hydrochloride IP 200 mg | | Life Sciences | | | | | | | Pvt. Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 22 | L-Carnitine L-Tartrate, | Each film coated tablet contains: | 1 Tablet | M/s Windlas | 16.39 | | | Methylcobalamin & Folic | L-Carnitine L-Tartrate eq. to L- | | Biotech Ltd./ | | | | Acid Tablets | Carnitine 500 mg | | M/s Glensmith | | | | | Methylcobalamin IP 1500 mcg | | Labs Pvt. Ltd. | | | | | Folic Acid IP 1.5 mg | | | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 23 | Levosalbutamol & | Each 2.5 ml contains: | 1 ml | M/s Axa | 6.32 | | | Ipratropium Bromide | Levosalbutamol Sulphate IP eq. to | | Parenterals | | | | Respirator Solution | Levosalbutamol 0.63 mg | | Ltd./ | | | | | Ipratropium Bromide IP eq. to | | M/s Mankind | | | | | Ipratropium (Anhydrous) 500 mcg | | Pharma Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 24 | Lobeglitazone Sulfate & | Each film coated bilayered tablet | 1 Tablet | M/s Akums | 10.34 | | | Metformin Hydrochloride | contains: | | Drugs & | | | | (Extended Release) | Lobeglitazone Sulfate 0.5 mg | | Pharmaceutica | | | | Tablets | Metformin Hydrochloride IP 500 mg | | ls Ltd./ | | | | | (As Extended release) | | M/s Zuventus | | | | | | | Healthcare | | | | | | | Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 25 | Lobeglitazone Sulfate & | Each film coated bilayered tablet | 1 Tablet | M/s Akums | 11.99 | | | Metformin Hydrochloride | contains: | | Drugs & | | | | (Extended Release) | Lobeglitazone Sulfate 0.5 mg | | Pharmaceutica | | | | Tablets | Metformin Hydrochloride IP 1000 mg | | ls Ltd./ | | | | | (As Extended release) | | M/s Zuventus | | | | | | | Healthcare | | | | | | | Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 26 | Methylprednisolone | Each uncoated tablet contains: | 1 Tablet | M/s Foregen | 6.00 | | | Tablets | Methylprednisolone IP 8 mg | | Healthcare | | | | | | | Ltd./ | | | | | | | M/s Zorvia | | | | | | Healthcare | | | | | | Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 27 | Metoprolol Succinate | Each film coated tablet contains: | 1 Tablet | M/s Akums | 11.99 | | | (Extended Release), | Metoprolol Succinate IP 23.75 mg eq. to | | Drugs & | | | | Chlorthalidone & | Metoprolol Tartrate 25 mg (As | | Pharmaceutica | | | | Telmisartan Tablets | extended-release) | | ls Ltd./ | | | | | Chlorthalidone IP 12.5 mg | | M/s Primus | | | | | Telmisartan IP 40 mg | | Remedies Pvt. | | | | | | | Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 28 | Metoprolol Succinate | Each film coated tablet contains: | 1 Tablet | M/s Akums | 14.44 | | | (Extended Release), | Metoprolol Succinate IP 47.50 mg eq. to | | Drugs & | | | | Chlorthalidone & | Metoprolol Tartrate 50 mg (As | | Pharmaceutica | | | | Telmisartan Tablets | extended-release) | | ls Ltd./ | | | | | Chlorthalidone IP 12.5 mg | | M/s Primus | | | | | Telmisartan IP 40 mg | | Remedies Pvt. | | | | | | | Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 29 | Olanzapine & | Each film coated tablet contains: | 1 Tablet | M/s Windlas | 10.64 | | | Fluoxetine Tablets | Olanzapine IP 5 mg | | Biotech Ltd./ | | | | | Fluoxetine Hydrochloride IP eq. to | | M/s Cadila | | | | | Fluoxetine 20 mg | | Pharmaceutica | | | | | | | ls Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 30 | Olanzapine & | Each film coated tablet contains: | 1 Tablet | M/s Windlas | 13.40 | | | Fluoxetine Tablets | Olanzapine IP 10 mg | | Biotech Ltd./ | | | | | Fluoxetine Hydrochloride IP eq. to | | M/s Cadila | | | | | Fluoxetine 20 mg | | Pharmaceutica | | | | | | | ls Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 31 | Paracetamol & | Each 5 ml contains: | 1 ml | M/s Foregen | 0.79 | | | Mefenamic Acid | Paracetamol IP 125 mg | | Healthcare | | | | Suspension | Mefenamic Acid IP 50 mg | | Ltd./ | | | | | | | M/s Zorvia | | | | | | | Healthcare | | | | | | | Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 32 | Paracetamol, Caffeine, | Each uncoated tablet contains: | 1 Tablet | M/s Unispeed | 4.52 | | | Diphenhydramine | Paracetamol IP 500mg | | Pharmaceutica | | | | Hydrochloride & | Caffeine (Anhydrous) IP 30mg | | ls Pvt. Ltd./ | | | | Phenylephrine | Diphenhydramine Hydrochloride IP | | M/s Smart | | | | Hydrochloride Tablets | 25mg | | Laboratories | | | | | Phenylephrine Hydrochloride IP 5 mg | | Pvt. Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 33 | Relugolix, Estradiol & | Each film coated tablet contains: | 1 Tablet | M/s Macmillon | 120.62 | | | Norethindrone Acetate | Relugolix 40 mg | | Pharmaceutica | | | | Tablets | Estradiol Hemihydrate USP eq. to | | ls Pvt. Ltd./ | | | | | Estradiol 1 mg | | M/s Alembic | | | | | Norethindrone Acetate USP 0.5 mg | | Pharmaceutica | | | | | | | ls Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 34 | Relugolix, Estradiol & | Each tablet contains: | 1 Tablet | M/s Macmillon | 107.22 | | | Norethindrone Acetate | Relugolix 40 mg | | Pharmaceutica | | | | Tablets | Estradiol Hemihydrate USP eq. to | | ls Pvt. Ltd./ | | | | | Estradiol 1 mg | | M/s Emcure | | | | | Norethindrone Acetate USP 0.5 mg | | Pharmaceutica | | | | | | | ls Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 35 | Relugolix, Estradiol & | Each film coated tablet contains: | 1 Tablet | M/s Macmillon | 107.22 | | | Norethindrone Acetate | Relugolix 40 mg | | Pharmaceutica | | | | Tablets | Estradiol Hemihydrate USP eq. to | | ls Pvt. Ltd./ | | | | | Estradiol 1 mg | | M/s Jagsonpal | | | | | Norethindrone Acetate USP 0.5 mg | | Pharmaceutica | | | | | | | ls Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 36 | Relugolix, Estradiol & | Each film coated tablet contains: | 1 Tablet | M/s Macmillon | 107.22 | | | Norethindrone Acetate | Relugolix 40 mg | | Pharmaceutica | | | | Tablets | Estradiol Hemihydrate USP eq. to | | ls Pvt. Ltd./ | | | | | Estradiol 1 mg | | M/s Aristo | | | | | Norethindrone Acetate USP 0.5 mg | | Pharmaceutica | | | | | | | ls Pvt. Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 37 | Relugolix, Estradiol & | Each tablet contains: | 1 Tablet | M/s Macmillon | 116.00 | | | Norethindrone Acetate | Relugolix 40 mg | | Pharmaceutica | | | | Tablets | Estradiol Hemihydrate USP eq. to | | ls Pvt. Ltd./ | | | | | Estradiol 1 mg | | M/s Zydus | | | | | Norethindrone Acetate USP 0.5 mg | | Healthcare | | | | | | | Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 38 | Relugolix, Estradiol & | Each film coated tablet contains: | 1 Tablet | M/s Akums | 110.00 | | | Norethindrone Acetate | Relugolix 40 mg | | Drugs & | | | | Tablets | Estradiol Hemihydrate IP eq. to | | Pharmaceutica | | | | | Anhydrous Estradiol 1 mg | | ls Ltd./ | | | | | Norethindrone Acetate USP 0.5 mg | | M/s Intas | | | | | | | Pharmaceutica | | | | | | | ls Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 39 | Telmisartan, Amlodipine | Each film coated tablet contains | 1 Tablet | M/s Pure & | 12.19 | | | & Hydrochlorothiazide | Telmisartan IP 40 mg | | Cure | | | | Tablets | Amlodipine Besilate IP eq. to | | Healthcare | | | | | Amlodipine 5 mg | | Pvt. Ltd./ | | | | | Hydrochlorothiazide IP 12.5 mg | | M/s Alkem | | | | | | | Wellness Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 40 | Telmisartan, | Each film coated tablet contains: | 1 Tablet | M/s Akums | 14.44 | | | Chlorthalidone | Telmisartan IP 40 mg | | Drugs & | | | | & Metoprolol Succinate | Chlorthalidone IP 12.5 mg | | Pharmaceutica | | | | (ER) Tablets | Metoprolol Succinate IP 47.50 mg eq. to | | ls Ltd./ | | | | | Metoprolol Tartrate 50 mg (As | | M/s Alkem | | | | | extended-release) | | Wellness Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 41 | Telmisartan, | Each film coated tablet contains: | 1 Tablet | M/s Akums | 11.99 | | | Chlorthalidone | Telmisartan IP 40 mg | | Drugs & | | | | & Metoprolol Succinate | Chlorthalidone IP 12.5 mg | | Pharmaceutica | | | | (ER) Tablets | Metoprolol Succinate IP 23.75 mg eq. to | | ls Ltd./ | | | | | Metoprolol Tartrate 25 mg (As | | M/s Alkem | | | | | extended-release) | | Wellness Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ | 42 | Vitamin D3 | Each 5 ml contains: | 1 ml | M/s Foregen | 15.74 | | | Oral Solution | Cholecalciferol IP 60000 IU | | Healthcare | | | | | (in Nano Droplet Form) | | Ltd./ | | | | | | | M/s Zorvia | | | | | | | Healthcare | | | | | | | Ltd. | | +-----+--------------------------------------------------------+--------------------------------------------------------------------------------+----------+-------------------------------------------------------------+---------+ Notes: (a) The manufacturer of above-mentioned formulations i.e., "new drug" under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove. (b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form-V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. (d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies. (f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2), (3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded. [PN/277/145/2026/F / F. No. 8(145)/2026/D.P./NPPA-Div.-II] BHIVA RAM YADAV, Asstt. Director Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064 and Published by the Controller of Publications, Delhi-110054.